Clinical trials: Insulin Pump Users

Type 1 Diabetes, Insulin Pump Users

Feasibility Study of the Solo™ Insulin Pump

• Completed
• Age: 16 to 60 years
• Phase 1
• Medical device

The purpose of this study is to assess the safety and usability of the Solo™ insulin MicroPump in subjects with type 1 diabetes who are pump users.

Trial name

NCT01055951

Testing

Solo MicroPump

Where

3 sites in Austria, Israel

Volunteers

90 people

Sponsor

Medingo Ltd